ID   HeLa IFITM2/3-KO
AC   CVCL_B0A5
SY   IFITM2/3 Knockout; C5-2
DR   Wikidata; Q108820453
RX   PubMed=30643282;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 5413; IFITM2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 5414; IFITM3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=30643282; DOI=10.1038/s41589-018-0213-2;
RA   Spence J.S., He R.-N., Hoffmann H.-H., Das T., Thinon E., Rice C.M.,
RA   Peng T., Chandran K., Hang H.C.;
RT   "IFITM3 directly engages and shuttles incoming virus particles to
RT   lysosomes.";
RL   Nat. Chem. Biol. 15:259-268(2019).
//